Skip to main content

Product Focus

PF: Pneumococcal 21-valent Conjugate (Capvaxive™) Vaccine – HDRX

October 18, 2024

Vaccines to Prevent Pneumococcal Infection and Disease Pneumococcal disease is common in young children, but older adults are at the greatest risk of seriousillness and death. Pneumococcal pneumonia is the most common clinical manifestation of pneumococcal disease in adults. It leads to 150,000 US hospitalizations annually and is estimated to account for 10 to 30%…

Product Focus: mResvia® (RSV Vaccine 60+)

October 10, 2024

Moderna mResvia® – Recommendations & Details For patients aged 60 or older, the risk of severe RSV infection and hospitalization can be high—making protection by vaccination that much more important. Respiratory Syncytial Virus (RSV) can cause significant lower respiratory tract disease in older patients, especially those with comorbidities identified by the CDC as heightened risk…

Product Focus: Aspruzyo Sprinkle® [Ranolazine]

December 14, 2022

Description: ASPRUZYO Sprinkle contains ranolazine, an antianginal available as white to off-white coated extended-release granules filled in unit-dose sachets containing 500 mg or 1000 mg. Indications & Dosage: ASPRUZYO Sprinkle is indicated for the treatment of chronic angina. ASPRUZYO Sprinkle may be used with beta-blockers, nitrates, calcium channel blockers, anti‑platelet therapy, lipid-lowering therapy, ACE inhibitors,…

Product Focus: Regranex® (becaplermin, rh-PDGF)

October 3, 2022

REGRANEX® (BECAPLERMIN) GEL IS BACK IN STOCK FROM SMITH & NEPHEW, INC Description: REGRANEX® gel is the only FDA-approved PDGF for the treatment of diabetic neuropathic ulcers, formulated to act as a first-line treatment following effective ulcer care. REGRANEX® gel features endogenous platelet-derived growth factor (PDGF) therapy, shown to initiate the healing process by attracting…

Gemtesa (Vibegron) feature blog header image

Product Focus: Gemtesa® (Vibegron)

May 10, 2022

Description: Vibegron is a selective beta-3 adrenergic agonist. Like mirabegron, vibegron relaxes detrusor smooth muscle and increases bladder capacity, reducing incontinence. Indication & Dosage: For the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urinaryurgency, and urinary frequency.Oral dosage: Adults: 75 mg PO once daily Adults & Geriatric Maximum Daily Dose: 75…

Product Focus: PAXLOVID

January 4, 2022

PAXLOVID – Oral Antiviral Treatment for COVID-19 The FDA has recently granted emergency use authorization (EUA) for PAXLOVID. Paxlovid is nirmatrelvir tablets co-packaged with ritonavir tablets, both antiviral agents. Both agents must be administered together. In clinical trials, PAXLOVID significantly reduced the risk of hospitalization or death for any cause by 89% compared to placebo…

Caregiver comforting man

Product Focus – Nuplazid (pimavanserin)

July 29, 2021

Parkinson’s Disease Parkinson’s Disease: A disorder of the central nervous system that affects movement, often including tremors. Approximately 1 million people in the US live with Parkinson’s disease (PD). More than 50% will develop Parkinson Disease Psychosis (PDP) during the course of their disease. Hallucinations associated with PD is the strongest independent predictor of nursing…

Elderly woman being treated by a nurse

Product Focus – Santyl Ointment (Collagenase)

July 19, 2021

Indication and Description Santyl Ointment is indicated for debriding dermal ulcers and severely burned areas. Dosage Collagenase Santyl Ointment should be applied once daily, or more frequently if the dressing becomes soiled, as from incontinence. When clinically indicated, crosshatching thick eschar with a #10 blade allows Collagenase Santyl Ointment more surface contact with necrotic debris….